WEDNESDAY, OCTOBER 18, 2017

Merck, NewLink Genetics team up to work on experimental Ebola vaccine

Merck and NewLink Genetics Corp. said they have entered into an exclusive worldwide license agreement to perform research and develop NewLink’s investigational Ebola vaccine rVSV-EBOV. Read More »

Physician who had Ebola released after Aethlon Hemopurifier treatment

An Ebola patient reportedly has been discharged from Frankfurt University Hospital in Germany. Read More »

Study shows mixing education, medicine and incentives my boost HPV vaccinations

Health professionals have conducted a study in integrating traditional education and incentives to advance vaccine rates for Human Papilloma (HPV) in both boys and girls. Read More »

Four Aethlon Hemopurifier units shipped to Omaha's NMC to fight Ebola

Aethlon Medical Inc. is hoping its first shipment of its Hemopurifier to the United States will help treat Ebola patients. Read More »

Health professionals recommit on World AIDS Day

Many health professionals see World AIDS Day as an opportunity to recommit to their battle against the disease by bringing greater awareness to it. Read More »

Two children die from flu in separate Florida counties

Two Florida children have died from the flu. Read More »

A new way to deliver vaccines being developed in Buffalo

New vaccine vehicles that contain genetically-engineered DNA to combat HIV, cancer and the flu are being developed at the University at Buffalo. Read More »